Insights


Treating Spinal Muscular Atrophy (SMA)

June 15th 2021

John Brandsema, MD, and Julie Parsons, MD, review the diagnosis and optimal management of spinal muscular atrophy.

Recent Breakthroughs in the Treatment of Alzheimer Disease

June 11th 2021

Experts in the diagnosis and treatment of Alzheimer disease discuss the recent approval of aducanumab, its implications on the field, and other promising therapies and diagnostic technologies in development.

Patient Compliance with Treatments for Epilepsy

May 20th 2021

An expert neurologist provides insight into epilepsy treatments and various factors that impact patient compliance.

Management of Tuberous Sclerosis Complex

May 20th 2021

Elizabeth Thiele, MD, PhD, and Peter Crino, MD, PhD, discuss the diagnosis and management of tuberous sclerosis complex (TSC) as well as unmet needs in the field.

Use of High-Efficacy Therapies for Treatment of Relapsing Multiple Sclerosis

May 20th 2021

Key opinion leaders in the management of relapsing/remitting multiple sclerosis, Enrique Alvarez, MD, PhD and Lawrence Steinman, MD, review key factors to consider when using high-efficacy therapies and provide an overview of emerging data for potential new treatment options.

Dystrophin and Its Role in Effective Treatment of Duchenne Muscular Dystrophy

May 13th 2021

Vamshi K. Rao, MD, and Eric P. Hoffman, PhD, discuss how dystrophin relates to Duchenne Muscular Dystrophy, current approved therapies, and treatments in development.

The Patient-Centered Visit & Shared Decision Making in the Management of Migraine

April 30th 2021

A discussion regarding the stigma associated with migraine and the importance of empowering patients and health care professionals to become involved in migraine advocacy.

Managing OFF Episodes in Parkinson’s Disease

April 14th 2021

Experts in neurology Laxman Bahroo, DO and Mindy K. Bixby, DO share insights into the diagnosis, management, and treatment of OFF episodes in Parkinson’s disease and highlight key therapeutic options currently available and in development.

Diagnosis and Management of Multiple Sclerosis in Pediatric Patients

March 30th 2021

Key opinion leaders in neurology Tanuja Chitnis, MD and Lauren B. Krupp, MD discuss the diagnosis and treatment of pediatric multiple sclerosis (MS) and provide insight into the impact that results from the PARADIGM trial of fingolimod in pediatric patients may have on the treatment landscape.

Treating Narcolepsy and Excessive Daytime Sleepiness

March 8th 2021

Phyllis Zee, MD, PhD, and Alon Avidan, MD, MPH, provide an overview of behavioral and pharmacological approaches to the management of excessive daytime sleepiness (EDS) and narcolepsy and discuss the recent approval of agents with new mechanisms of action.